Abena O. Appiah-Kubi

Abena O. Appiah-Kubi

Pediatric Hematology Oncology
269-01 76th Avenue
Suite 255
New Hyde Park, NY 11040

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Coping Strategies and Social Support for Transition Readiness Among Youth With Sickle Cell Disease.

Coping Strategies and Social Support for Transition Readiness Among Youth With Sickle Cell Disease.

Journal: JAMA network open
Published: July 13, 2026

Hydroxyurea pharmacokinetics, it is a small world after all.

Hydroxyurea pharmacokinetics, it is a small world after all.

Journal: Blood advances
Published: January 16, 2026

Recruitment and retention of young adults with sickle cell disease.

Recruitment and retention of young adults with sickle cell disease.

Journal: Health care transitions
Published: December 22, 2025

Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related support.

Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related support.

Journal: Health care transitions
Published: December 22, 2025

A novel US-based grading system for disease severity in sickle cell disease: the Sickle Cell Outcome Grading System (SCOGS).

A novel US-based grading system for disease severity in sickle cell disease: the Sickle Cell Outcome Grading System (SCOGS).

Journal: The Lancet. Haematology
Published: December 22, 2025

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Journal: Blood advances
Published: December 19, 2025

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Journal: Blood advances
Published: December 19, 2025

Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial.

Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial.

Journal: JAMA network open
Published: November 17, 2025

Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study.

Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study.

Journal: Pediatric blood & cancer
Published: October 17, 2025

HABIT Efficacy Trial Intervention Improves Elements of General and Disease-Specific Quality of Life in Youth With Sickle Cell Disease.

HABIT Efficacy Trial Intervention Improves Elements of General and Disease-Specific Quality of Life in Youth With Sickle Cell Disease.

Journal: Pediatric blood & cancer
Published: June 20, 2025

PIVOTing the Course of HbSC Disease.

PIVOTing the Course of HbSC Disease.

Journal: NEJM evidence
Published: January 28, 2025

The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial.

The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial.

Journal: JMIR research protocols
Published: December 03, 2024
Showing 1-12 of 31

Last Updated: 09/26/2026